OptimizeRx Corp
Research OptimizeRx Corp (OPRX) on Bullrun: market cap USD 148.03M, P/E 33.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOPRX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Market capUSD 148.03M
- P/E33.4
- Financial periodQ1 2026
- RevenueUSD 19.84M
- Net incomeUSD 6.84M
- Free cash flowUSD 14.45M
- Gross margin75.2%
Valuation Snapshot
latest market cap is USD 148.03M; P/E is 33.4.
Peer valuation comparison
Latest P/E is 33.42x versus a Healthcare sector median of 24.46x (36.6% above).
Latest P/E is 33.42x versus a United States median of 24.87x (34.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 109.43M | USD 5.13M | USD 18.66M | 67.3% | 0.27 | USD 23.37M | USD 25.68M | USD 128.29M |
| FY2024 | USD 92.13M | -USD 20.11M | USD 4.78M | 64.5% | -1.1 | USD 13.38M | USD 32.82M | USD 117.00M |
| FY2023 | USD 71.52M | -USD 17.57M | -USD 7.33M | 60.0% | -1.03 | USD 13.85M | USD 36.23M | USD 126.55M |
| FY2022 | USD 1.03M | -USD 11.44M | USD 10.57M | 3801.6% | -0.64 | USD 18.21M | USD 277.48K | USD 126.11M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 148.03M | 33.4 | n/a | n/a |
| 2025 | 2025-12-31 | USD 229.99M | 47.2 | n/a | n/a |
| 2024 | 2024-12-31 | USD 89.68M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 259.76M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 288.17M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.11B | 3105.5 | n/a | n/a |
About OptimizeRx Corp
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is OptimizeRx Corp's market cap?
OptimizeRx Corp's market capitalization is USD 148.03M.
What is OptimizeRx Corp's P/E ratio?
OptimizeRx Corp's price-to-earnings (P/E) ratio is 33.4.
What does OptimizeRx Corp do?
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and.